SYRINGE DRIVER POLICY
Document History
Version Date:
July 2012
Version Number:
2
Status:
Next Revision
Due:
Developed by:
Approved
Policy Sponsor:
Assistant Director Integrated Community Based Services
EQIA completed:
EIA/CHANNAN/14062012
Approved by:
Clinical Effectiveness Group
Date Approved:
14th September 2012
July 2014
Workforce Development Lead Trainer
Revision History
Version
2
Revision
Date
June 2012
June 2012
2
Mar 2014
Summary of Changes
Updated to reflect general practice and ease of use
for practitioners.
New format and update section 5.3 including:
Added a sentence 'Please make a note of the rate
ml/hr at this stage'. Added a sentence on when to
apply the keypad lock after setting up the syringe
driver; and section 10 for training.
Changes to Syringe Driver allocation
To help ensure that this policy is as accessible as possible, it has been left-aligned and is
available in alternative formats and languages. To obtain a copy of the policy in large
print, audio, Braille (or other format) or in a different language, please contact The
Communications Team, by Tel: 01773 525099 or email communications@dchs.nhs.uk
TABLE OF CONTENTS
1.
Background ................................................................................................................. 3
2.
Aim /Purpose .............................................................................................................. 3
3.
Definitions and an Explanation of Terms Used........................................................ 3
4.
Intended Users. ........................................................................................................... 4
5.
Full Details of the Policy ............................................................................................ 4
5.1 20ml/30ml BD Plastipak luer lock syringes. ............................................................ 4
5.2 Administration line .................................................................................................. 4
5.3 BD Saf-T-Intima™ 22 Gauge cannula (blue), stores code number L003052. ......... 5
5.4 Choice of infusion site ............................................................................................. 5
5.5 Labelling ................................................................................................................. 6
5.6 Procedure: First time set up of the syringe pump. .................................................. 7
5.7 Reasons for Alarms: ............................................................................................. 10
5.8 Documentation and monitoring ............................................................................. 11
5.9 Transfer to another care setting. ........................................................................... 12
5.10 Risk management ............................................................................................... 13
5.11 Cleaning and Decontamination ........................................................................... 13
6.
Support and Additional Contacts ............................................................................ 14
7.
References and Associated Documents ................................................................ 14
8.
Trust Accountability / Responsibilities ................................................................... 14
9.
Monitoring & Performance Management of the Policy.......................................... 16
10.
Equality Impact Statement ................................................................................... 16
11.
Appendices ............................................................................................................ 16
Appendix 1 ....................................................................................................................... 17
Appendix 2 ....................................................................................................................... 17
Appendix 3 ....................................................................................................................... 17
Appendix 4 ....................................................................................................................... 17
Appendix 5 ....................................................................................................................... 17
12.
.
Equality and Impact Assessment ........................................................................ 17
SYRINGE DRIVER POLICY
1.
BACKGROUND
The use of a portable battery operated syringe driver for subcutaneous medications is now
a well established technique in palliative care; this view is supported by Dickman et al
2005. The syringe driver “allows for a minimally invasive route of drug administration,
which produces relatively constant levels of medication which avoids peaks, which can
result in reduced symptom control” (Twycross and Wilcock, 2002).
Palliative care patients often present with multiple symptoms that can necessitate the need
for several drug treatments. If the patient’s condition deteriorates and the oral route
cannot be used a continuous subcutaneous infusion via the syringe driver provides a
simple and effective way to control symptoms (Dickman et al 2005).
In 2010 the National Patient Safety Agency (NPSA) issued an alert which asks NHS
organisations to ensure that syringe pumps have:
a) Rate settings in ml per hour;
b) Mechanisms to stop infusion if the syringe is not properly and securely fitted;
c) Alarms that activate if the syringe is removed before the infusion is stopped.
Derbyshire Community Health Services (DCHS) NHS Trust, after consultation, opted for
the McKinley T34 syringe pump, which will replace the Graseby MS16A and MS26. This
pump is small in size, and has a large LCD display which provides error messages and
context sensitive instructions. The device includes a rolling 512 date and time stamped
event log, mechanical syringe sensors that interlock with the syringe and provision of
alarms during incorrect operation thus complying with IEC 60601-2-24 standards. The
McKinley T34 is calibrated in ml/hour.
2.
AIM /PURPOSE
A subcutaneous infusion pump is an effective method of administering therapeutic drugs
via subcutaneous route, which can no longer be tolerated orally or rectally by the patient.
The aim of this policy is to provide guidance for staff in the use of the McKinley T34 pump
across adult services. Using a uniform policy will reduce the level of risks associated with
syringe pump management and will facilitate the introduction of the McKinley T34 Syringe
pump within DCHS NHS Trust.
3.
DEFINITIONS AND AN EXPLANATION OF TERMS USED
A syringe pump is a medical device, which is a small portable, battery operated
infusion pump. It is used to deliver medication via the subcutaneous route over a
calculated period of time providing a continuous level of medication.
Version Number 2
Page 3 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
4.
INTENDED USERS.
Table of Intended Users:
DCHS
Finance Performance and Information
Quality
Strategy
Service Delivery
Human Resources
Medical Directorate
Leicester Employees
No
No
No
Yes
No
Yes
No
Within this policy where it states “all employees”, please note that it relates to all the
employees who are highlighted in the table above
5.
FULL DETAILS OF THE POLICY
Equipment required
5.1 20ml/30ml BD Plastipak luer lock syringes.
This provides sufficient dilution to reduce the risk of adverse site reactions and
incompatibility, without providing too large a volume for comfortable administration. If the
medications total is greater than 10ml before dilution, it may be necessary to use a 30ml
syringe and dilute further.
Size of BD Plastic Luer Lock Syringe
20ml syringe
30ml syringe
50ml syringe (Exceptional circumstances)
Maximum fill volume as stated in
user manual
18ml
23ml
34ml
5.2 Administration line
A 100cm luer lock Codan manometer line is recommended (Code FSB066) it requires
0.8ml to prime.
NB this manometer line has been identified as cost effective and in line with medicine
administration requirements.
Version Number 2
Page 4 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
5.3 BD Saf-T-Intima™ 22 Gauge cannula (blue), stores code number L003052.
The BD Saf-T-Intima cannula, shown above, is the choice of cannula for SC medications
at DCHS. The rationale for this preference is:
 Site reactions are less common
 Insertion is less traumatic
 Needle stick injury is reduced to patient and staff
 Less expensive that alternative Teflon devices
 Can remain in situ longer than other devices (Dawkins et al, 2000)
Note: The BD Saf-T-Intima cannula has a dead space of 0.2ml. It is NOT primed before or
after insertion. If a patient is started on a continuous SC infusion they will require a
separate BD Saf-T-Intima cannula for bolus medications.
The medication should be flushed with at least 0.2ml of Water for Injection to
accommodate the dead space.
5.4 Choice of infusion site
Acceptable SC cannula insertion sites (see diagram 1):
 Anterior aspect of the upper arms or anterior abdominal wall
 Anterior aspect of thigh
 The scapula if the patient is distressed and /or agitated
 Anterior chest wall (least common)
Sites not suitable for insertion:
 Skin folds and breast tissue
 Directly over a tumour site
 Lymphoedematous limb or oedema – absorption may be reduced
 The abdominal wall if ascites is present
 Bony prominences – little SC tissue, absorption reduced
 Previously irradiated skin – skin may be sclerosed, poor blood supply
 Sites near a joint – uncomfortable, increased risk of displacement
 Infected, broken or bruised skin
If a local reaction occurs, the cannula should be recited using a fresh cannula and
administration set. If this recurs, consider further diluting the drug(s).
Version Number 2
Page 5 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
The cannula may remain in place for up to seven days, unless removal is indicated
Diagram 1 – Acceptable SC Cannulation sites
5.5 Labelling



All syringes containing drug additives must be fully labelled.
If there is any doubt as to the contents of a syringe, the contents should be
discarded. (This is particularly important for continuity of care, especially where
patients transfer from one care setting to another).
Complete the label details in black ink
The label should state:
 The name, Date of Birth and NHS Number of the patient for whom it is intended.
 The date and time of preparation
 The initials of the persons preparing and checking the contents
 The name and dose of all the drugs
 The name of the diluent
Attach label to the syringe. Ensure the label does not interfere with the mechanism of the
infusion device, i.e. where there is contact with the barrel clamp arm. Flag the label at the
tip end of the syringe, leaving the scale visible so that it can still be read.
Version Number 2
Page 6 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
McKinley T34 Syringe Pump
Syringe Flange/Collar
sensor
Barrel Clamp Arm and
Sensor
Plunger sensor
Actuator
Infusion light status
indicator: Green running
Red - stopped
Power
ON/OFF
INFO
Scroll
UP/DOWN
YES/NO
NO/STOP
Actuator movement
Forward (FF)/Back
Best Practice Point:
For many patients the setting up of a syringe driver is a response to unrelieved symptoms.
Following initial set-up of the driver it takes 4-6 hours for drugs to reach therapeutic blood
levels. Therefore, if the patient is experiencing unrelieved symptoms, consider the use of a
PRN breakthrough dose which can be administered before the syringe pump is set up.
5.6 Procedure: First time set up of the syringe pump.



Wash hands with bactericidal soap and water.
Adhere to Aseptic Non-Touch Technique (ANTT) principles throughout the
procedure.
Ensure that the Saf-T-Intima cannula has been inserted/ or reassessed that it is in
good condition for use.
Procedure.
1. Ensure barrel clamp arm is down and no syringe in place.
2. Press ON/OFF key to power up for 2 to 3 seconds - the actuator moves (preloading) and the first four screens display automatically.
ALWAYS allow the pre-loading programme to complete and the flashing
syringe icon to appear BEFORE loading the syringe onto the pump.
3. Software version and pump identification is then displayed.
T34
Version NCAT xxxxxx
ID: (hospital number)
Version Number 2
Page 7 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
The actuator is moving to the position of the syringe
that was in place at the start of the previous infusion.
The pump will then display the default settings
Check Battery level: Press blue INFO key then YES.
In the community, batteries reading less than 40% at
the start of a 24 hour infusion should be changed.
For community hospitals this will be when ‘low
battery alert displayed’.

Pre-loading
USE NO to interrupt
Occlusion
750mmHg
Max rate
5ml/hr
Program lock ON
Battery status 85%
Load syringe
* flashing syringe image*
Load Syringe - Secure the syringe onto the pump ensuring that the syringe is
placed correctly in the plunger and collar sensors.
If Necessary, align syringe to sensors and use the FF/BACK keys to move the
actuator for syringe placement
4. If the syringe size/brand displayed matches the one used, confirm by
pressing YES.
5. Infusion summary displays.
DO NOT CONFIRM, remove the syringe.
Please make a note of the rate ml/hr at this stage.
Volume
15.0ml
Duration
24:00
Rate
0.62ml/hr
Confirm, Press YES
6. Attach syringe to the extension set and prime the set manually. Slide clamp
across the administration set to prevent siphoning.
7. Reload the syringe; use the FF key to adjust actuator.
8. If the syringe size/brand displayed matches the one used, confirm by
pressing YES.
20ml BD Plastipak
Select ↑↓, press YES
9. Press YES to resume
10. Check all settings displayed on screen and
confirm by pressing YES.
Version Number 2
Page 8 of 17
Press YES to resume,
No for New Syringe
Volume
14.1ml
Duration
22:40
Rate
0.62ml/hr
Confirm, Press YES
Policy date June 2012
SYRINGE DRIVER POLICY
Connect the primed administration line to the Saf-T-Intima cannula.
11. Press YES to start the infusion when ready to
do so.
Start Infusion?
12. Infusion running. (Alternating last line messages)
Time Remaining 22.40
Rate 0.62ml/hr
20ml BD Plastipak

Time Remaining 22.40
Rate 0.62ml/hr
<<<Pump Delivering
Press and hold down the blue info key and wait for the keypad lock to be activated.
The syringe pump panel must be locked when not in use by a staff member.

The McKinley T34 syringe pump should be secured in the locked box provided –
this will protect the syringe from accidental knocks.
Each ward will have two keys, one per team, located on the CD keys. In the
community each community nurse will have their own key, which they are
responsible for. This key should not be left in the patient's home.
What to do when changing the syringe:
When a new syringe is due to be loaded into the pump;
 Stop the infusion.
 Press and hold the info key to deactivate the keypad lock facility.
 The pump should be turned off and the infused syringe removed.
 Switch pump back on again, allowing pre-loading programme to complete. This is to
ensure that the previous programme is cleared.
 Follow steps 1 – 6
 At step 7 press yes to confirm. The reason for this is the administration line is
already primed.
If the syringe pump does not undergo the preloading sequence and gives the option of
resuming a previous programme. THIS OPTION MUST NOT BE TAKEN. A new
programme MUST be set for each syringe change.
If this occurs, staff must check that the keypad lock function is off and turn off the syringe
pump.
 Turn the syringe pump back on
 The syringe pump will then undergo the preloading sequence.
 Continue to set up the syringe pump.
When the pump is no longer required:

Stop the infusion – note how many millimetres remain in the syringe and that
this corresponds with the syringe infusion summary.
Version Number 2
Page 9 of 17
Policy date June 2012
SYRINGE DRIVER POLICY





Press and hold the info key to deactivate the keypad lock facility.
Switch off the pump.
Remove the battery
Clean as specified in section 5.10
Follow DCHS Medicine Code for the correct removal and disposal of parental
drug therapy.
5.7 Reasons for Alarms:
Screen
Low battery
Program nearly complete
Pump paused too long
End battery
End program
Syringe
syringe
displaced,
Description
Alert: Battery is almost
depleted
Alert: Infusion will end soon
Alarm: Pump has been left
in STOP mode (on hold) for
2 minutes
Alarm: Battery is depleted
Alarm: Infusion is complete
Check Alarm: One or more of the
syringe detection sensors is
not detecting
Occlusion
Alarm: Patient access
Check line and syringe – device is blocked, occluded,
see
below for further clamped or kinked
information.
Implication/action
Prepare to change the
battery.
Prepare to change syringe
or turn pump off
Either start the infusion,
continue pause or turn the
pump off
Change battery
Close down or start a new
infusion
Check screen messages for
assistance.
Check the syringe and reseat as necessary
Replace access device,
release the clamp or un-kink
tubing.
Changing the battery in the middle of an infusion:









Make a note of rate ml/hr, volume to be infused and volume left to be infused and
duration left
Stop the syringe pump
Deactivate keypad lock and turn the syringe pump off
Replace battery
Turn syringe pump back on
There will be no preloading sequence as the syringe has not been removed from
the syringe pump.
The syringe pump will ask a prompt question
Press YES to resume.
NO for a New Syringe
Press YES to resume
Infusion summary displays
Volume
12.0ml
Duration
16.25
Rate
0.70ml/hr
Confirm, Press YES
Version Number 2
Page 10 of 17
Policy date June 2012
SYRINGE DRIVER POLICY

Check this information with what was documented before turning off the pump, if all
matches, press YES to confirm.
What to do in the event of an occlusion:
If the pump alarms, indicating an occlusion, press stop.
Check the administration line for kinks or damage and check the cannula site.
What to do if the cannula is no longer viable: (note all infusion summary
information)
 Place clamp on administration line.
 Disconnect the administration set from the Saf-T-Intima cannula.
 A new cannula should be sited.
 Reconnect the administration line to the cannula, remove the clamp and press yes
to start.
What to do if the administration line is no longer viable: (note all infusion summary
information)
 Place clamp on the Saf-T-Intima cannula.
 Detach the administration line from the Saf-T-Intima cannula and syringe.
 Attach a new administration line and prime.
 Use FF key to realign the actuator, reload on to the pump.
 Press start on the syringe pump
Press YES to resume.
NO for a New Syringe
 Press YES to resume.
The pump will recalculate the volume and keep the infusion time the same.
5.8 Documentation and monitoring
The Subcutaneous Infusion Monitoring Form (Appendix 1 for Hospital staff and Appendix 2
for Community staff) must be used to record details of preparation and subsequent
administration and monitoring.
The following must be documented:
 details of preparation and commencement
 checks at 1 hour after commencement or syringe change and at 4 hourly intervals
in Community Hospitals and 24 hourly intervals if patients are being cared for by
community nursing services: site appearance (no redness, pooling swelling, pain,
hardness)
 Rate of infusion(according to infusion chart)
 Syringe/line contents appearance (absence of clouding, crystallisation or colour
change)
Volume remaining: check the amount displayed to be infused corresponds with the
amount within the syringe pump
 Volume infused
 Battery status (shown as a percentage on the display panel on the front of the
syringe pump).
 Any problem noted and action taken.
 Disposal of any remaining syringe contents.
Version Number 2
Page 11 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
5.9 Transfer to another care setting.
It is essential to contact the relevant health professional who will be receiving the patient,
i.e. District Nursing Team, ward team as soon as the admission/discharge date/time is
known and inform them of plan to admit/discharge patient with a McKinley T34 syringe
driver.

For community/hospital staff receiving patients with a syringe pump insitu, they will
need to change the pump on first visit and return to the discharging service (e.g.
DHU, acute hospital, hospice or community hospital).

Spare syringe pumps will be located at the following sites:
Hospital/ Area
Babington Hospital
Baron Ward
Ilkeston Community
Hospital
Oakwell Ward
Cavendish Hospital
Fenton Ward
Ashgate Hospice
(The Ward)
Address
Derby Road, Belper, Derbyshire DE56
1WH
Heanor Road, Ilkeston, Derbyshire DE7
8LN
Contact Number
01773 824171
Manchester Road, Buxton, Derbyshire
SK17 6TE
Ashgate Road, Old Brampton, Chesterfield
S42 7JD
01298 212800
Bolsover Hospital
Rowan Ward
Swadlincote Health
Centre.
Only until 6.30pm. After
this time care homes
would contact 111 or
Rightcare if the patient is
registered.
Welbeck Road, Bolsover, Chesterfield S44
6DH
Civic Way, Swadlincote, Derbyshire DE11
0EA
01246 827901
01159 305522
01246 568801
01283 818000

Hospital staff to complete the Syringe Pump Loan Sheet (Appendix 3), it is the
wards responsibility to follow up the loan of any equipment if it has not been
returned to the ward.

For patients who are residents (regardless of status, nursing or residential) in care
homes then community nursing teams are the first contact for a syringe pump.

If all community nursing teams syringe driver are in use, then care home staff
should contact the nearest hospital or health centre to obtain a syringe driver. This
should be collected by care home staff with valid identification.

It is recommended that all equipment used in the community setting for setting up a
syringe pump and for the administration of PRN anticipatory doses are kept
together in a designated syringe pump box. DO NOT LEAVE A KEY TO THE
SYRINGE PUMP IN THE PATIENTS HOME.
Version Number 2
Page 12 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
5.10 Risk management



Care must be taken to ensure that The McKinley T34 is NOT immersed in water
In the event of an incident, an incident form must be completed.
Annual service and maintenance must be carried out.
What defines an incident?
 Administration of incorrect medication, dose and /or diluent
 Infusions completing ahead of time or carrying on beyond intended time of
completion
 Device not alarming
 Any other incident or near miss which may compromise patient safety or comfort.
Where there has been a problem with the syringe pump it must be sent to the Medical
Engineering Department for investigation. The medical engineering department will have
access codes to access the pumps event logs. You need to ensure that the pump has
been decontaminated prior to going for inspection. A completed certificate of
decontamination must be completed (see appendix 5) and kept with the pump for the
medical engineering department. The certificate can be located within the Medical
Devices Policy.
5.11 Cleaning and Decontamination
Carry out cleaning of the syringe pump and lockbox with Clinell wipes as per DCHS
Patient Equipment Cleaning policy. If any additional cleaning is required e.g.
contamination with bodily fluids or cleaning the threads of the screws the actuator moves
along, contact your local Medical Engineering Department and/or Infection Prevention &
Control Team for advice. Do not use chemicals such as Xylene, acetone/similar solvents
as this will damage components and labels. Lockboxes should not be cleaned with
alcohol-based products as this causes the lockbox to become more brittle.
Lock boxes (figure 1) must be cleaned with Acticlor if contaminated with blood or body
fluids or in contact with a patient with a known infection, refer to DCHS Decontamination
Policy.
Figure 1 - Lock Box
The syringe pump must never be submerged in water, and if it is accidentally dropped in
water, it must be withdrawn from use immediately and sent to the Medical Engineering
Department.
The re-usable pouch can be cleaned with detergent based wipes containing water or
alcohol. When thorough cleaning is required machine wash at 30ºc. Do not bleach or
iron.
Version Number 2
Page 13 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
6.
SUPPORT AND ADDITIONAL CONTACTS
Yvonne Jackson Workforce Development Lead Trainer - Tel: 01246 515627
Donna Wilson Workforce Development Lead Trainer - 07500993779
Malcolm Steward Head of Medicines Management - Tel: 01246 253056
North County - Medical Engineering Department - Tel: 01629 812525
South County - Clinical Engineering Department The Royal Derby Hospital Tel 01332
788031
7.
REFERENCES AND ASSOCIATED DOCUMENTS
DCHS Hand Hygiene Policy
DCHS Consent Policy
DCHS Medical Devices Policy
DCHS Record Keeping Policy
DCHS Patient Equipment Cleaning Policy
Dickman A. et al. (2005) The Syringe Driver. University Press, Oxford.
Hunt T. (2002) in: Pension J. Fisher R. Palliative care for people with Cancer. Arnold,
London:
National Patient Safety Agency Rapid Response Report (2010) NPSA/2010/RRR019
Safer Ambulatory Syringe Drivers
McKinley T34 Ambulatory Syringe Pump Operation Manual, March 2006
8.
TRUST ACCOUNTABILITY / RESPONSIBILITIES
8.1
Individuals:
8.1.1 Chief Executive
The Chief Executive has responsibility for the DCHS Board for ensuring that there are safe
and effective systems in place to deliver high quality services.
8.1.2 Director of Service Delivery
The Director of service Delivery is responsible for the high quality, efficient and effective
community services provided by the four Service Delivery divisions within the Trust,
ensuring that they meet and exceed performance standards.
8.1.3 Director of Quality / Chief Nurse
The Director of Quality / Chief Nurse is responsible for the professional leadership of non
medical clinicians across the Trust and for ensuring the highest possible quality of care for
patients and service users. The Director of Quality is also responsible for the development
and implementation of effective strategies and systems to improve patient safety and
patient experience across the Trust
8.1.4 Assistant Director
Version Number 2
Page 14 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
The Assistant Director of Integrated Community Based Services is responsible for service
delivery.
8.1.5 Operational Managers
The Operational Managers have a responsibility to ensure that the policy is implemented
within their area and that their teams are aware of the policy and have received the
appropriate training.
8.1.6 Employees
Professionally registered employees; all employees are accountable for their professional
practice and hold individual responsibility to maintain their knowledge and skills.
All employees have a responsibility to be aware of and read policies appropriate to their
roles and others where necessary. They should be aware of, and comply with, their
responsibilities within the individual policies of the Trust.
8.1.7 Policy Sponsor
The policy sponsor is responsible for ensuring that:





the policy is developed in line with this framework
the policy is disseminated to its target audience;
appropriate training is given in the use of the policy;
the policy is properly implemented.
its implementation is monitored and reviewed on a regular basis.
The policy sponsor is the Assistant Director of Integrated Community Based Services.
8.2
Committees:
8.2.1 DCHS Board
The DCHS Board has ultimate responsibility for DCHS. The Board’s prime duty is to
ensure good governance throughout the Trust and act in the best interests of the public for
the services DCHS provides.
8.2.2 Governance Committee
The Governance Committee (GC) has delegated authority from the DCHS Board and is
responsible for ensuring that controls are in place to support the achievement of DCHS’
business objectives, whilst minimising its exposure to corporate, financial and clinical risks.
8.2.3 Quality Committee
The Quality Committee is responsible for ensuring the delivery and integration of the
clinical governance agenda across DCHS including monitoring ongoing compliance with
the CQC Registration.
8.2.4 Risk Committee
The Risk Committee is responsible for providing strategic leadership on the management
of risks and ensuring that controls are in place to support the achievement of DCHS
business objectives, while minimising its exposure to all risks.
8.2.5 Safety Committee
The Safety Committee is responsible for providing overall assurance on the safety
management systems (integrating patient safety and health & safety) within DCHS and
ensuring processes are in place, to meet statutory, mandatory and legislative safety
requirements.
Version Number 2
Page 15 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
8.2.6 Education Development & Learning Committee
Education Development and Learning Committee is responsible for ensuring that there is a
robust strategy to enable the workforce of DCHS to be competent to deliver the highest
quality of professional services to the people of Derbyshire.
9.
MONITORING & PERFORMANCE MANAGEMENT OF THE POLICY
Training
 All staff using the McKinley T34 syringe driver must be competent and
professionally accountable in the use and operation of this device.
 Staff must have attended a McKinley T34 pump training session and complete the
competency workbook, this is provided by Workforce Planning and Development
Team.
 Staff can utilise the e-learning package provided by CME for the Mckinley T34, as
an update.
http://www.dchs.nhs.uk/assets/public/dchs/dchs_staff_zone/your_development/elea
rning%20/E%20Learning%20Algorythm%20June%202011.doc
 Records of staff training will be held on electronic staff record (ESR).
 All staff must complete bi-annual updates. Training will be advertised on the
Learning and Development intranet site.
Minimum Requirement
Duties/Responsibilities
Monitoring
Who
Frequency
Review
Review of
policy
Policy
Development
Group
2 Yearly –
Policy review
Clinical
Effectiveness
Group
Process including any flow charts
Training
Monitoring
Appendices (If required)
Equality Impact Assessment
(EIA)
10.
EQUALITY IMPACT STATEMENT
We welcome feedback on this policy and the way it operates. We are interested to know
of any possible or actual adverse impact that this policy may have on any groups in
respect of age, disability, gender reassignment, marriage and civil partnership, pregnancy
and maternity, race, religion or belief, sex and sexual orientation.
The person responsible for equality impact assessment of this policy is Caroline Hannan
Tel 01159316200
This policy has been screened to determine equality relevance for the following equality
groups: age, disability, gender reassignment, marriage and civil partnership, pregnancy
and maternity, race, religion or belief, sex and sexual orientation. The policy is considered
to have high equality relevance. A full impact assessment will be conducted by August
2012
11.
APPENDICES
Version Number 2
Page 16 of 17
Policy date June 2012
SYRINGE DRIVER POLICY
Appendix 1
Subcutaneous Infusion Monitoring Form – Hospital
Appendix 2
Subcutaneous Infusion Monitoring Form - Community
Appendix 3
Syringe Pump Loan Sheet
Appendix 4
T34 Lock On Load and Prime Quick User Guide
T34 Lock On Load
Prime QUG v1 May 2011.pdf
Appendix 5
Certificate of Decontamination
12.
Certificate of
Decontamination.doc
EQUALITY AND IMPACT ASSESSMENT
The EIA has been determined as low rated. Click here to access the EIA web page.
Version Number 2
Page 17 of 17
Policy date June 2012